Sinopharm Kicks Off National Emergency Allocation System For Medical Reserves
This article was originally published in PharmAsia News
On the instruction of the National Development and Reform Commission, China National Pharmaceutical Group Corporation (Sinopharm) has shipped the first batch of ventilators, ECG monitors, surgical instruments and transfusion equipment to earthquake-hit regions in Sichuan. Responsible for national medical reserves, Sinopharm has set up an emergency allocation system and a group leading rescue efforts. All subsidiaries involved in the exercise are tasked to ensure the specifications and quantity of medical reserves correspond to NDRC's predetermined catalog, as well as make emergency procurement of necessary medicines and devices outside the catalog. Logistics centers in Beijing, Shanghai and Tianjin and major warehouses have been notified to stand by for medical allocation assignments at a moment's notice. (Click here for more - Chinese Language)
You may also be interested in...
After talking with the FDA, Atox will file an NDA for its necrotizing soft tissue infections therapy despite missing primary endpoints in a pivotal trial, the biotech’s CEO tells Scrip.
Faced with the risk of losing their investment from a possible stock delisting amid prosecutors’ probes into company’s management, SillaJen’s individual minority shareholders are demanding the Korea Exchange resume trading of the biotech’s stock, in a rare united move.
Merck/Eisai face US speed bump for combo in first-line liver cancer after FDA decision and although their Phase III trial is already enrolled, completion is not due until 2022, giving time for new competitor to make its mark.